Welcome Logout
Skip to main content

Register to get a COVID-19 vaccine

Get information about COVID-19

Site Logo

National Cancer Control Programme

  • Home
  • About Us - National Cancer Services
    • Regional Cancer Services
    • NCCP Structure
  • Cancer Prevention
  • Patients and Families
    • About Cancer
    • Cancer Screening
    • Cancer Treatments
      • Surgery
      • Radiotherapy
      • Cancer Drugs
    • Information Leaflets and Booklets
    • Useful Links
    • Publications, Research and Intelligence
  • Publications, Research and Intelligence
    • Reports
    • Cancer Intelligence
    • NCCP Guidelines and Policies
    • NCCP Research
  • NCCP Consultations
  • Health Professionals
    • Cancer Nursing Programme
    • Community Pharmacy
    • Survivorship Programme
    • Psycho-Oncology Programme
    • Primary Care Resources
      • GP Referral Guidelines and Forms
      • GP Electronic Referral System
      • Useful Links
    • Interhospital Referrals
      • Pancreatic Cancer
    • Cancer Screening
    • Hereditary Cancer Genetics
    • NCCP Chemotherapy Regimens
      • Breast
      • CAR-T Therapy
      • Gastrointestinal
      • Genitourinary
      • Gynaecology
      • Head & Neck
      • Leukemia
      • Lung
      • Lymphoma
      • Myeloma
      • Neuroendocrine
      • Neuro-oncology
      • Oral Anti-Cancer Medicines
      • Paediatric
      • Sarcoma
      • Skin / Melanoma
      • Transplant
    • Clinical Practice Guidelines
      • Breast Cancer
      • Prostate Cancer
      • Lung Cancer
      • Gestational Trophoblastic Disease
      • Ovarian Cancer
      • Oesophageal Cancer
    • Medical Oncology and Haemato-oncology
      • SACT Guidance, Documents and Resources
      • Dose Banding for Systemic Anticancer Therapy
      • Cancer Drug Management Programme
      • NCCP Technology Review Committee
      • Oncology Medication Safety Review
      • National Meeting
      • NCIS
      • Contact the National Medical Oncology and Haemato-oncology Programme
    • Education and Training Resources
      • Nurse training
    • Publications, Research and Intelligence
    • Useful Links
    • Radiation Oncology
  • News and Events: Cancer Services
  • About Us - National Cancer Services
  • Cancer Prevention
  • Patients and Families
  • Publications, Research and Intelligence
  • NCCP Consultations
  • Health Professionals
  1. National Cancer Control Programme
  2. Health Professionals
  3. Hereditary Cancer Genetics

NCCP Clinical Genetics Cancer Testing Criteria

These are the agreed BRCA1/2 cancer susceptibility gene testing criteria.  Referrals are accepted by the Department of Clinical Genetics at CHI, at Crumlin and St James’s Cancer Genetic Service. Click here to download the criteria document.

 
  • About Us - National Cancer Services
  • Cancer Prevention
  • Patients and Families
  • Publications, Research and Intelligence
  • NCCP Consultations
  • Health Professionals
    • Cancer Nursing Programme
    • Community Pharmacy
    • Survivorship Programme
    • Psycho-Oncology Programme
    • Primary Care Resources
    • Interhospital Referrals
    • Cancer Screening
    • Hereditary Cancer Genetics
    • NCCP Chemotherapy Regimens
    • Clinical Practice Guidelines
    • Medical Oncology and Haemato-oncology
    • Education and Training Resources
    • Publications, Research and Intelligence
    • Useful Links
    • Radiation Oncology
  • News and Events: Cancer Services

    Contact Us

    For questions about health services, your entitlements, or how to access HSE health or social services in your area?

    You can phone HSELive to speak to one of our agents on: 

    1800 700 700
    00 353 1 240 8787 (from outside Ireland)

    Get more information about this service including opening hours

     © 2021 Health Service Executive

    • HSELive - We're here to help
    • Cookie Statement
    • Accessibility
    • Privacy Statement
    • Disclaimer